SynAct Pharma AB (STO:SYNACT)
16.04
-0.18 (-1.11%)
Nov 2, 2026, 4:11 PM CET
SynAct Pharma AB Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SynAct Pharma AB stock has an average price target of kr 34.70. The average 1-year stock price forecast is 116.33% higher than the current stock price, while the lowest is kr 30.00 (+87.03%) and the highest is kr 39.40 (+145.64%).
Price Target: kr 34.70 (+116.33%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
There are currently no analyst ratings available for SynAct Pharma AB.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Forecast
Revenue This Year
44.25M
Revenue Next Year
21.60M
from 44.25M
Decreased by -51.19%
EPS This Year
-1.68
from -2.17
EPS Next Year
-0.98
from -1.68
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.